Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study

  1. Callejo, A.
  2. Faouzi, S.
  3. Bouché, O.
  4. Bertucci, F.
  5. Chevalier, T.
  6. Isambert, N.
  7. Duffaud, F.
  8. Collard, O.
  9. Penel, N.
  10. Terrier, P.
  11. Mir, O.
  12. Blay, J.Y.
  13. Le Cesne, A.
Revue:
Targeted Oncology

ISSN: 1776-260X 1776-2596

Année de publication: 2021

Volumen: 16

Número: 4

Pages: 485-492

Type: Article

DOI: 10.1007/S11523-021-00820-7 GOOGLE SCHOLAR